AdvaVet is a pharmaceutical company focused on innovative treatments within animal oncology. Our product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients (API), without the addition of toxic solvents.
There are currently no fully-approved injectable chemotherapeutic drugs for companion animals. We believe our formulation may result in improved safety, efficacy and ease of administration. Our initial development and commercialization efforts are focused on creating novel formulations of well-established chemotherapeutic drugs that can be used for the treatment of cancer in companion animals.